Obesity
Type 2 Diabetes and Weight Loss Therapies: The Hype, Hope, and Your Heart
GLP-1 drugs were once met with skepticism, but now their proven health benefits have brought them unprecedented levels of hype. Researchers talked about how we got here and what they hope to see next for these life-changing medications.
How To Stay Strong on a GLP-1
GLP-1 medications are very effective for weight management, but can also cause muscle loss. People who use them – or really any weight loss strategy – should prioritize maintaining their muscle health. Nutrition and regular exercise are key to building and maintaining strength while losing weight.
Groundbreaking Trial Testing Tirzepatide for Type 1 Diabetes
For the first time, researchers are exploring the effectiveness of tirzepatide – which is currently only approved for type 2 diabetes – for people with type 1 diabetes and obesity or overweight.
Zepbound Reversed Prediabetes, Prevented Progression to Type 2 for Nearly Everyone, Study Shows
URMOUNT-1 clinical trial shows tirzepatide (marketed as Mounjaro, Zepbound) prevented the progression of prediabetes to type 2 diabetes by 99%.
Diabetes, Eating Disorders, and Obesity: Navigating the Complexities of Treatment
People with diabetes are at a higher risk of developing eating disorders. Things get even more complicated when obesity is involved. Here’s why compassionate care and specialized treatment are so important.
With New Diabetes Data, Our CEO Issues a Call to Action
Diabetes now affects 1 in 6 adults in the U.S., with obesity driving rates higher. Learn how prevention, awareness, and action can transform the future of this epidemic.